Carteolol hydrochloride

CAS No. 51781-21-6

Carteolol hydrochloride ( NSC 300906; OPC 1085 )

Catalog No. M14804 CAS No. 51781-21-6

A non-selective beta blocker used as an anti-arrhythmia agent, an anti-angina agent, an antihypertensive agent, and an antiglaucoma agent.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
10MG 28 In Stock
25MG 43 In Stock
50MG 65 In Stock
100MG 102 In Stock
200MG 151 In Stock
500MG 254 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Carteolol hydrochloride
  • Note
    Research use only, not for human use.
  • Brief Description
    A non-selective beta blocker used as an anti-arrhythmia agent, an anti-angina agent, an antihypertensive agent, and an antiglaucoma agent.
  • Description
    A non-selective beta blocker used as an anti-arrhythmia agent, an anti-angina agent, an antihypertensive agent, and an antiglaucoma agent.Other Indication Approved
  • Synonyms
    NSC 300906; OPC 1085
  • Pathway
    Angiogenesis
  • Target
    Adrenergic Receptor
  • Recptor
    β-adrenergicreceptor
  • Research Area
    Other Indications
  • Indication
    Other Disease

Chemical Information

  • CAS Number
    51781-21-6
  • Formula Weight
    328.83
  • Molecular Formula
    C16H25ClN2O3
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO: 13.33 mg/mL
  • SMILES
    CC(C)(C)NCC(COC1=CC=CC2=C1CCC(=O)N2)O.Cl
  • Chemical Name
    2(1H)-Quinolinone, 5-[3-[(1,1-dimethylethyl)amino]-2-hydroxypropoxy]-3,4-dihydro-,hydrochloride (1:1)

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Silodosin

    A highly potent, uroselective α1a-adrenoceptor antagonist with Ki of 36 pM; displays 583- and 56-fold lower potency against α1b and α1d respectors, respectively.

  • Levosalbutamol

    A short-acting β2 adrenergic receptor agonist used in the treatment of asthma and chronic obstructive pulmonary disease (COPD).

  • TAK-259

    A potent and selective human α1D adrenoceptor (α1D-AR) antagonist with Ki of 1.1 nM; displays 200-fold and 800-fold selectivity against α1A- and α1B-AR, respectively.